17-03-2020 12:00 via medpagetoday.com

Demyelinating Risks With Anti-TNF Vary in Rheumatic Diseases

]]>(MedPage Today) -- Patients with certain types of arthritic conditions were at elevated risk for developing neuroinflammatory events if treated with tumor necrosis factor (TNF) inhibitors, a large prospective cohort study conducted in Denmark and...
Read more »